Overview
Cardiospondylocarpofacial syndrome (CSCF syndrome), also known as Sotos-like syndrome or previously as cardio-spondylo-carpo-facial syndrome, is an extremely rare genetic disorder characterized by a combination of cardiac, vertebral, carpal (wrist bone), and facial abnormalities. The condition is caused by mutations in the MAP3K7 gene, which encodes a protein involved in important signaling pathways during development. Key clinical features include congenital heart defects (such as atrial and ventricular septal defects, patent ductus arteriosus), vertebral segmentation anomalies, carpal and tarsal bone synostosis (fusion of wrist and ankle bones), short stature, and distinctive facial features. The facial characteristics may include a broad forehead, hypertelorism (widely spaced eyes), short nose with a broad nasal bridge, and micrognathia (small jaw). Additional features can include hearing loss, dental anomalies, and mild intellectual disability in some cases. The syndrome affects multiple body systems including the cardiovascular, skeletal, and craniofacial systems. Skeletal manifestations may also include scoliosis, fused cervical vertebrae, and brachydactyly (short fingers). The condition is present from birth, with many features identifiable in the neonatal or early infantile period. There is no specific cure for cardiospondylocarpofacial syndrome, and management is supportive and symptom-based. Treatment typically involves cardiac surgery or monitoring for heart defects, orthopedic management for skeletal abnormalities, and developmental support as needed. Regular follow-up with a multidisciplinary team including cardiologists, orthopedic specialists, and geneticists is recommended.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Cardiospondylocarpofacial syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Cardiospondylocarpofacial syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Cardiospondylocarpofacial syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Cardiospondylocarpofacial syndrome.
Community
No community posts yet. Be the first to share your experience with Cardiospondylocarpofacial syndrome.
Start the conversation →Latest news about Cardiospondylocarpofacial syndrome
No recent news articles for Cardiospondylocarpofacial syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Cardiospondylocarpofacial syndrome
What is Cardiospondylocarpofacial syndrome?
Cardiospondylocarpofacial syndrome (CSCF syndrome), also known as Sotos-like syndrome or previously as cardio-spondylo-carpo-facial syndrome, is an extremely rare genetic disorder characterized by a combination of cardiac, vertebral, carpal (wrist bone), and facial abnormalities. The condition is caused by mutations in the MAP3K7 gene, which encodes a protein involved in important signaling pathways during development. Key clinical features include congenital heart defects (such as atrial and ventricular septal defects, patent ductus arteriosus), vertebral segmentation anomalies, carpal and ta
How is Cardiospondylocarpofacial syndrome inherited?
Cardiospondylocarpofacial syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Cardiospondylocarpofacial syndrome typically begin?
Typical onset of Cardiospondylocarpofacial syndrome is neonatal. Age of onset can vary across affected individuals.